A closer look at the role of urotensin II in the metabolic syndrome.
about
Urotensin II inhibits skeletal muscle glucose transport signaling pathways via the NADPH oxidase pathway.The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophyUrotensin-II-Mediated Reactive Oxygen Species Generation via NADPH Oxidase Pathway Contributes to Hepatic Oval Cell ProliferationUrotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
P2860
A closer look at the role of urotensin II in the metabolic syndrome.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
A closer look at the role of urotensin II in the metabolic syndrome.
@ast
A closer look at the role of urotensin II in the metabolic syndrome.
@en
type
label
A closer look at the role of urotensin II in the metabolic syndrome.
@ast
A closer look at the role of urotensin II in the metabolic syndrome.
@en
prefLabel
A closer look at the role of urotensin II in the metabolic syndrome.
@ast
A closer look at the role of urotensin II in the metabolic syndrome.
@en
P2860
P356
P1476
A closer look at the role of urotensin II in the metabolic syndrome.
@en
P2093
Adel Giaid Schwertani
Pierre-Olivier Barrette
P2860
P356
10.3389/FENDO.2012.00165
P577
2012-12-28T00:00:00Z